Alogliptin
NDC 45802-150, Alogliptin, tablet, film coated, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-150
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022271
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALOGLIPTIN BENZOATE25 mg/1
Pharmacologic classes
Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-150-65 | 45802015065 | 30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b25f155a-1259-47c2-aa3b-7c1356e4c7f6NADAC price for package 45802015065
GET /v1/drugs/nadac/45802015065
Use it
Look up 45802-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.